Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.
Beneficial cardiovascular results were consistent across subgroups regardless of diabetes status or medication combinations.
Read More »New Approval for Dapagliflozin to Treat Patients with Heart Failure
Pre-Diabetes Increases Risk of CVD and All-Cause Mortality
Numerous complications associated with diabetes, including the risk of death, begin at the pre-diabetic stage.
Read More »Do Pre-Diabetes Patients Fall into a Gray Zone?
Findings from a recently published meta-analysis of patients with pre-diabetes, with and without ASCVD, suggest an increased risk for premature death and cardiovascular events.
Read More »Preventing Heart Failure With Farxiga
The FDA has given a Fast Track Designation to accelerate study of Farxiga’s effect on reduction in mortality and heart failure after a heart attack.
Read More »Decreased Risk of Death Tied to the Use of Statins
The use of statins in veterans 75 years or older was associated with an overall reduced risk of morbidity and mortality.
Read More »Life Expectancy With CVD, CKD, and Diabetes
Explore the detriments associated with two of the most common diabetes comorbidities.
Read More »Macronutrient Intake Impacts Mortality for T2D
Study finds proportions of carbs, proteins and fats in the diet have differing effects on mortality risk for men and women with type 2.
Read More »The Effect of HbA1c Variability on Cardiovascular Disease
The new HbA1c variability score (HVS) allows HbA1c variability to be more easily and consistently studied.
Read More »Less Decrease in Death Rates in Younger Patients with Diabetes
Why are younger patients with diabetes not seeing the same improvements as those over 45?
Read More »New Study Reveals Diabetes is Among the Top Three COVID-19 Comorbidities
Hypertension, obesity, and diabetes found to be the most prevalent comorbidities among 5700 hospitalized patients with COVID-19 in the New York City Area.
Read More »